University of Colorado Denver CTO(CTRC) — Aurora, Colorado

University of Colorado Denver CTO(CTRC) is a clinical research site located in Aurora, Colorado, United States 80045.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

University of Colorado Denver CTO(CTRC) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Colorectal Carcinoma, Gastric Adenocarcinoma, GEJ Adenocarcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Colorado Denver CTO(CTRC)?

University of Colorado Denver CTO(CTRC) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Colorado Denver CTO(CTRC) conducted?

University of Colorado Denver CTO(CTRC) has 1 clinical trials on record, with 1 currently active. Their work covers Colorectal Carcinoma, Gastric Adenocarcinoma, GEJ Adenocarcinoma.

Is University of Colorado Denver CTO(CTRC) accredited by Crixeo Health?

University of Colorado Denver CTO(CTRC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Colorado Denver CTO(CTRC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.